B4GALT1 antibody (AA 50-215)

Catalog No. ABIN6137403

Product Details anti-B4GALT1 Antibody

Target: B4GALT1 (UDP-Gal:betaGlcNAc beta 1,4 Galactosyltransferase, Polypeptide 1 (B4GALT1))

Binding Specificity: AA 50-215

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This B4GALT1 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Sequence: LPQLVGVSTP LQGGSNSAAA IGQSSGELRT GGARPPPPLG ASSQPRPGGD SSPVVDSGPG PASNLTSVPV PHTTALSLPA CPEESPLLVG PMLIEFNMPV DLELVAKQNP NVKMGGRYAP RDCVSPHKVA IIIPFRNRQE HLKYWLYYLH PVLQRQQLDY GIYVIN

Cross-Reactivity: Human, Mouse, Rat

Characteristics: Polyclonal Antibodies

Purification: Affinity purification

Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 50-215 of human B4GALT1 (NP_001488.2).

Isotype: IgG

Application Details

Application Notes: WB,1:500 - 1:2000,IHC,1:50 - 1:100

Comment:

HIGH QUALITY

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Avoid freeze / thaw cycles.

Target Details for B4GALT1

Target: B4GALT1 (UDP-Gal:betaGlcNAc beta 1,4 Galactosyltransferase, Polypeptide 1 (B4GALT1))

Alternative Name: B4GALT1 (B4GALT1 Products)

Synonyms: B4GAL-T1 antibody, CDG2D antibody, GGTB2 antibody, GT1 antibody, GTB antibody, beta4Gal-T1 antibody, B-1,4-GalT antibody, B-1,4-GalT1 antibody, GalT antibody, Ggtb antibody, Ggtb2 antibody, b4Gal-T1 antibody, beta-1,4-GalT antibody, beta-1,4-GalT1 antibody, beta-1,4-galactosyltransferase 1 antibody, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 antibody, B4GALT1 antibody, B4galt1 antibody

Background: This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. This gene is unique among the beta4GalT genes because it encodes an enzyme that participates both in glycoconjugate and lactose biosynthesis. For the first activity, the enzyme adds galactose to N-acetylglucosamine residues that are either monosaccharides or the nonreducing ends of glycoprotein carbohydrate chains. The second activity is restricted to lactating mammary tissues where the enzyme forms a heterodimer with alpha-lactalbumin to catalyze UDP-galactose + D-glucose <=> UDP + lactose. The two enzymatic forms result from alternate transcription initiation sites and post-translational processing. Two transcripts, which differ only at the 5' end, with approximate lengths of 4.1 kb and 3.9 kb encode the same protein. The longer transcript encodes the type II membrane-bound, trans-Golgi resident protein involved in glycoconjugate biosynthesis. The shorter transcript encodes a protein which is cleaved to form the soluble lactose synthase.,B4GALT1,B4GAL-T1,CDG2D,GGTB2,GT1,GTB,beta4Gal-T1,beta-1,Signal Transduction,Cell Biology & Developmental Biology,Apoptosis,Endocrine & Metabolism,Lipid Metabolism,Cardiovascular,Angiogenesis,B4GALT1

Molecular Weight: 42 kDa/43 kDa

Gene ID: 2683

UniProt: P15291

Pathways: Glycosaminoglycan Metabolic Process